DexCom (DXCM) Stock

While there is always a strong need for good medical care, the healthcare industry is constantly changing. Just because a company offers important medical services doesn't mean it is a good investment.

Being a long-term investor can be challenging, especially when dealing with the ups and downs of the stock market. This is especially true if you choose to buy and hold your investments during both rising and falling markets.

DXCM and OURA, a company that makes smart rings, are working together to help people make better choices about their diet, exercise, and general health.

On Tuesday, medical device company Dexcom announced that it will put $75 million into Ōura's newest funding round, which gives the smart ring company a valuation of more than $5 billion.

If you want to keep track of your vital signs like an Olympic athlete, you should be excited about the partnership between glucose-monitor company DexCom and Oura smart rings.

SAN DIEGO--(BUSINESS WIRE)--On this World Diabetes Day, DexCom, Inc. (NASDAQ: DXCM), a leader in glucose monitoring technology, is urging individuals with diabetes worldwide to start exploring their health. Research indicates that almost 70% of those diagnosed with diabetes felt unsure about how to begin their health journey, and nearly half reported that diabetes has restricted their ability to follow their interests. For National Diab.

The stocks of these mid-sized companies, which have strong competitive advantages, seem appealing because they are undervalued.

This medical device company is struggling, but it is not finished yet.

Investors probably believed that with an exciting new product available, the company should have shown more significant growth.